Antibiotics Market Size, Industry, Trend, Growth Analysis By 2028

The antibiotics market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028.

Antibiotics are powerful medicines that are used to fight against bacterial infections and diseases. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. Antibiotics either kill the bacteria (bactericidal) or restrict it from reproducing and growing (bacteriostatic). The antibiotics market do not work against any viral infection. Some of the common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat), and among others.

Market Insights

Increasing Development of Generic Drugs

A generic medicine is a copy of a branded drug that is no longer under patent. Generic versions are introduced in the market with an aim to offer cost-efficient drugs and increase the reach of these drugs to people belonging to different economic classes. Generic versions are popular due to their availability and affordability. For instance, according to a study published on the NCBI in 2018, the average brand name prescription price was almost 4-times the average generic price. Additionally, the companies are also focusing on the development of generic versions with an aim to offer antibiotics at minimal costs. For instance, in June 2018, Lupin launched generic Tobramycin inhalation solution in the US market. Further, encouragement from government authorities is also projected to drive the production of generic antibiotics, which would eventually drive the growth of the antibiotics market during the forecast period. For instance, in February 2019, the US Food and Drug Administration (US FDA) announced approval for commercialization of generic medicines manufactured by Indian drug companies in the US.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Antibiotics Market: Strategic Insights

Antibiotics Market

• 
  CAGR (2020 - 2028)

  4.0%
• Market Size 2020
  US$ 44.11 Billion
• Market Size 2028
  US$ 59.25 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Pfizer, Inc
• Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
• Abbott,
• GlaxoSmithKline Plc,
• Sanofi,
• Novartis AG,
• Bayer AG,
• Bristol Myers Squibb Company,
• Eli Lilly and Company,

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Drug Class

• Sulfonamides
• Aminoglycosides
• Carbapenem
• Macrolides
• Fluoroquinolones
• Penicillin
• Cephalosporin
• Others

Action Mechanism

• Mycolic Acid Inhibitors
• RNA Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Protein Synthesis Inhibitors
• Cell Wall Synthesis Inhibitors

Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South and Central America

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Test Type Insights

Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2020; whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period.

Action-Mechanism Insights

Based on action mechanism, the antibiotics market has been segmented into mycolic acid inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, protein synthesis inhibitors, and cell wall synthesis inhibitors. The cell wall synthesis inhibitors segment held the largest share of the market in 2020, whereas the DNA synthesis inhibitors segment is estimated to register the highest CAGR in the market during the forecast period.

Product launches and approval strategies are commonly adopted by companies to expand their footprint and product portfolio worldwide and meet the growing demand.

The market players operating in the antibiotics market adopt the strategy of expansion to enlarge customer base across the world, which also permits the players to maintain their brand name globally. For instance, in July 2019, the company such as Pfizer has launched an international research consortium to discover and develop new TB antibiotics in collaboration with eight biotechnology partners and European academic.

Antibiotics Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Global Antibiotics Market – By Drug Class

• Cephalosporin
• Penicillin
• Fluoroquinolones
• Macrolides
• Carbapenem
• Aminoglycosides
• Sulfonamides
• Others

Global Antibiotics Market – By Action Mechanism

• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others

Global Antibiotics  – By Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

• Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa

• South America

  • Brazil
  • Argentina
  • Rest of South America

Company Profiles

• Pfizer, Inc
• Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
• Abbott,
•  GlaxoSmithKline Plc,
• Sanofi,
•  Novartis AG,
•  Bayer AG,
• Bristol Myers Squibb Company,
• Eli Lilly and Company,
• Astellas Pharma